All-cause and in-hospital mortality after aspirin use in patients hospitalized with COVID-19: a systematic review and meta-analysis.

Nischit Baral,Joshua D Mitchell,Pramod K Savarapu,Maxwell Akanbi,Bandana Acharya,Soumya Kambalapalli,Amith Seri,Krishna P Bashyal,Arvind Kunadi,Niranjan Ojha,Annabelle Santos Volgman,Tripti Gupta,Timir K Paul

Biology methods & protocols（2022）

引用 1|浏览1

暂无评分

摘要

Our study shows that aspirin decreases in-hospital mortality in patients hospitalized with COVID-19. Further studies are needed to assess which COVID-19 patient populations benefit most, such as patients on aspirin for primary versus secondary prevention of atherosclerotic disease. In addition, significant bleeding also needs to be considered when assessing the risk-benefit of aspirin use.

查看译文

关键词

COVID-19,all-cause mortality,aspirin,in-hospital mortality,meta-analysis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要